FIFilingIndexScreener · The Ledger
🔔 Save search
More filtersthe deep cuts
Valuation▼
P/SAny
FCF yieldAny
EV / EBITDAAny
Profitability▼
Gross marginAny
Net marginAny
Growth▼
Rev growthAny
Balance sheet▼
Debt / EquityAny
Dividend▼
Dividend yieldAny
Listing▼
Exchange
Country
Filter
194 of 3,901
Sort
01
UNHUNITEDHEALTH GROUP INC🔥
Healthcare · Healthcare Services
$371.00B-1.0%
P/E 29.0·P/S 0.8·Mgn 2.8%·ROE 12.0%·FCF 4.3%
F 6
02
AZNASTRAZENECA PLC🔥
Healthcare · Pharmaceuticals
$277.22B-0.7%
P/E 46.5·P/S 6.1·Mgn 13.0%·ROE 21.0%·FCF 4.2%
—
03
CVSCVS HEALTH Corp🔥
Consumer Staples
$130.09B-0.1%
P/E 15.5·P/S 0.4·Mgn 2.3%·ROE 2.4%·FCF 6.0%
F 6
Red 8-K
04
CICigna Group🔥
Healthcare · Healthcare Services
$78.83B-1.1%
P/E 12.5·P/S 0.3·Mgn 2.3%·ROE 14.3%·FCF —
F 8
05
ALNYALNYLAM PHARMACEUTICALS, INC.⚡
Healthcare · Pharmaceuticals
$37.76B+2.6%
P/E 120.4·P/S 10.2·Mgn 8.4%·ROE 39.8%·FCF 1.2%
F 6
Red 8-K
06
NTRANatera, Inc.🔥
Healthcare · Healthcare Services
$30.37B-0.3%
P/E —·P/S 12.1·Mgn -9.0%·ROE -12.2%·FCF 0.4%
—
Red 8-K
07
IQVIQVIA HOLDINGS INC.⚡
Healthcare · Biotechnology
$30.29B-0.0%
P/E 22.3·P/S 1.9·Mgn 8.3%·ROE 20.9%·FCF 6.8%
—
Red 8-K
08
BIIBBIOGEN INC.
Healthcare · Biotechnology
$29.53B-0.3%
P/E 21.5·P/S 3.0·Mgn 13.8%·ROE 7.1%·FCF 6.9%
F 5
13D
09
RPRXRoyalty Pharma plc⚡
Healthcare · Pharmaceuticals
$24.32B-1.8%
P/E 17.9·P/S 10.0·Mgn 55.7%·ROE 7.9%·FCF —
—
13D
10
UTHRUNITED THERAPEUTICS Corp⚡
Healthcare · Pharmaceuticals
$23.17B-0.6%
P/E 18.0·P/S 7.3·Mgn 40.6%·ROE 18.8%·FCF 4.5%
F 8
Red 8-K
11
DGXQUEST DIAGNOSTICS INC🔥
Healthcare · Healthcare Services
$22.48B-0.3%
P/E 20.9·P/S 2.0·Mgn 9.5%·ROE 13.8%·FCF 6.0%
F 8
12
ROIVRoivant Sciences Ltd.
Healthcare · Pharmaceuticals
$21.61B+1.9%
P/E —·P/S 2615.8·Mgn -4817.3%·ROE -6.6%·FCF -3.5%
—
13
INSMINSMED Inc
Healthcare · Pharmaceuticals
$21.21B+1.8%
P/E —·P/S 25.9·Mgn -144.4%·ROE -172.8%·FCF -4.6%
F 4
14
MRNAModerna, Inc.🔥
Healthcare · Biotechnology
$19.80B+0.5%
P/E —·P/S 8.9·Mgn -143.6%·ROE -32.6%·FCF -10.4%
F 3
15
NBIXNEUROCRINE BIOSCIENCES INC
Healthcare · Biotechnology
$16.06B-0.9%
P/E 24.0·P/S 5.2·Mgn 21.6%·ROE 14.7%·FCF 4.7%
F 6
Red 8-K
16
JAZZJazz Pharmaceuticals plc
Healthcare · Pharmaceuticals
$14.48B+1.4%
P/E 25.9·P/S 3.6·Mgn 13.8%·ROE -8.2%·FCF 9.0%
—
Red 8-K
17
BBIOBridgeBio Pharma, Inc.
Healthcare · Pharmaceuticals
$13.08B+3.4%
P/E —·P/S 22.6·Mgn -125.9%·ROE —·FCF -3.4%
F 2
13DRed 8-K
18
IONSIONIS PHARMACEUTICALS INC
Healthcare · Pharmaceuticals
$12.11B-1.7%
P/E —·P/S 11.4·Mgn -30.9%·ROE -78.0%·FCF -2.6%
F 3
Red 8-K
19
ICLRICON PLC⚡
Healthcare · Biotechnology
$11.19B+0.4%
P/E 20.2·P/S 1.4·Mgn 6.9%·ROE 2.5%·FCF 7.7%
—
20
RVTYREVVITY, INC.🔥
Healthcare · Diagnostics & Tools
$11.12B+0.0%
P/E 46.1·P/S 3.9·Mgn 8.4%·ROE 3.3%·FCF 4.6%
—
21
RDYDR REDDYS LABORATORIES LTD
Healthcare · Pharmaceuticals
$11.07B-2.5%
P/E 16.5·P/S 2.9·Mgn 17.6%·ROE 17.0%·FCF 2.0%
—
22
BMRNBIOMARIN PHARMACEUTICAL INC
Healthcare · Pharmaceuticals
$10.81B-0.8%
P/E 40.2·P/S 3.3·Mgn 8.3%·ROE 5.7%·FCF 6.7%
F 4
Red 8-K
23
ARWRARROWHEAD PHARMACEUTICALS, INC.
Healthcare · Pharmaceuticals
$10.50B+1.3%
P/E —·P/S 16.9·Mgn -43.7%·ROE -0.3%·FCF 1.5%
—
Red 8-K
24
KRYSKrystal Biotech, Inc.⚡
Healthcare · Biotechnology
$9.37B-1.7%
P/E 41.7·P/S 22.5·Mgn 53.9%·ROE 16.8%·FCF 2.0%
—
25
CORTCORCEPT THERAPEUTICS INC
Healthcare · Pharmaceuticals
$8.90B-1.1%
P/E 83.9·P/S 12.0·Mgn 14.3%·ROE 15.4%·FCF 1.6%
F 4
Red 8-K
26
ATRAPTARGROUP, INC.
Materials
$7.51B-0.1%
P/E 19.4·P/S 1.9·Mgn 10.0%·ROE 14.7%·FCF 4.0%
—
Red 8-K
27
GKOSGLAUKOS Corp
Healthcare · Medical Devices
$7.45B-1.7%
P/E —·P/S 14.7·Mgn -37.0%·ROE -28.6%·FCF -0.3%
F 2
28
PRAXPraxis Precision Medicines, Inc.⚡
Healthcare · Pharmaceuticals
$7.43B-4.5%
P/E —·P/S —·Mgn —·ROE -34.5%·FCF -3.4%
—
29
PTGXProtagonist Therapeutics, Inc
Healthcare · Pharmaceuticals
$7.06B+0.8%
P/E —·P/S 95.3·Mgn -154.9%·ROE -21.2%·FCF 0.8%
—
Red 8-K
30
IMVTImmunovant, Inc.
Healthcare · Biotechnology
$6.90B+0.1%
P/E —·P/S 276.7·Mgn -1039.5%·ROE -59.3%·FCF —
—
31
LQDALiquidia Corp
Healthcare · Pharmaceuticals
$6.33B+6.1%
P/E 284.0·P/S 22.0·Mgn 7.7%·ROE -154.0%·FCF -0.6%
—
32
PTCTPTC THERAPEUTICS, INC.
Healthcare · Pharmaceuticals
$6.23B0.0%
P/E —·P/S 7.5·Mgn -22.6%·ROE —·FCF 11.3%
—
Dilut.Red 8-K
33
CNTACentessa Pharmaceuticals plc
Healthcare · Pharmaceuticals
$6.15B+0.8%
P/E —·P/S —·Mgn —·ROE -37.5%·FCF -3.2%
—
13DRed 8-K
34
RYTMRHYTHM PHARMACEUTICALS, INC.⚡
Healthcare · Pharmaceuticals
$6.06B+0.9%
P/E —·P/S 27.9·Mgn -93.3%·ROE -141.3%·FCF -1.9%
F 6
Red 8-K
35
MIRMMirum Pharmaceuticals, Inc.
Healthcare · Pharmaceuticals
$6.06B-4.8%
P/E —·P/S 10.6·Mgn -140.2%·ROE -7.4%·FCF 0.9%
—
Dilut.
36
SRRKScholar Rock Holding Corp
Healthcare · Biotechnology
$5.29B+0.1%
P/E —·P/S —·Mgn —·ROE -154.0%·FCF -5.7%
—
37
CRSPCRISPR Therapeutics AG⚡
Healthcare · Biotechnology
$4.90B-3.2%
P/E —·P/S 1195.3·Mgn -13856.5%·ROE -30.3%·FCF -7.1%
—
Dilut.Red 8-K
38
TVTXTravere Therapeutics, Inc.⚡
Healthcare · Pharmaceuticals
$4.84B-2.6%
P/E —·P/S 9.0·Mgn -4.0%·ROE -22.2%·FCF —
F 7
Dilut.Red 8-K
39
TWSTTwist Bioscience Corp
Healthcare · Biotechnology
$4.74B+4.6%
P/E —·P/S 11.6·Mgn -19.8%·ROE -16.4%·FCF -1.6%
F 4
40
BLLNBillionToOne, Inc.⚡
Healthcare · Healthcare Services
$4.65B-0.3%
P/E 158.1·P/S 13.1·Mgn 8.3%·ROE 1.6%·FCF 0.3%
F 7
41
TNLTravel & Leisure Co.⚡
Consumer Discretionary
$4.63B-1.7%
P/E 20.1·P/S 1.2·Mgn 5.7%·ROE —·FCF 11.3%
—
42
DNTHDianthus Therapeutics, Inc. /DE/⚡
Healthcare · Pharmaceuticals
$4.49B+1.9%
P/E —·P/S 2203.6·Mgn -7973.3%·ROE -32.9%·FCF —
—
43
MANEVeradermics, Inc
Healthcare · Pharmaceuticals
$4.01B-0.5%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
13DDilut.
44
ZGNErmenegildo Zegna N.V.
Consumer Discretionary · Apparel & Textiles
$3.94B+1.2%
P/E 25.5·P/S 1.8·Mgn 7.1%·ROE 10.0%·FCF 7.4%
—
45
EWTXEdgewise Therapeutics, Inc.⚡
Healthcare · Pharmaceuticals
$3.75B-0.7%
P/E —·P/S —·Mgn —·ROE -32.1%·FCF —
—
13D
46
CRNXCrinetics Pharmaceuticals, Inc.
Healthcare · Pharmaceuticals
$3.63B+1.3%
P/E —·P/S 201.1·Mgn -2747.2%·ROE -46.9%·FCF -10.6%
F 2
Red 8-K
47
ACADACADIA PHARMACEUTICALS INC⚡
Healthcare · Pharmaceuticals
$3.61B+0.4%
P/E 9.6·P/S 3.3·Mgn 34.3%·ROE 31.9%·FCF 2.9%
F 6
Red 8-K
48
DNLIDenali Therapeutics Inc.
Healthcare · Biotechnology
$3.44B-0.7%
P/E —·P/S —·Mgn —·ROE -50.6%·FCF -12.3%
—
49
PHINPHINIA INC.
Consumer Discretionary · Autos
$3.15B+1.3%
P/E 24.3·P/S 0.9·Mgn 3.7%·ROE 8.2%·FCF 6.0%
F 6
50
RCUSArcus Biosciences, Inc.
Healthcare · Pharmaceuticals
$2.99B-0.8%
P/E —·P/S 12.7·Mgn -156.4%·ROE -55.9%·FCF -16.2%
—
51
TARSTarsus Pharmaceuticals, Inc.
Healthcare · Biotechnology
$2.67B+2.7%
P/E —·P/S 5.9·Mgn -14.7%·ROE -19.3%·FCF -0.8%
—
52
RAREUltragenyx Pharmaceutical Inc.
Healthcare · Pharmaceuticals
$2.40B+8.8%
P/E —·P/S 3.6·Mgn -90.9%·ROE —·FCF -19.7%
—
Red 8-K
53
BCRXBIOCRYST PHARMACEUTICALS INC
Healthcare · Biotechnology
$2.21B+4.7%
P/E —·P/S 2.5·Mgn -51.7%·ROE —·FCF 15.6%
F 7
Red 8-K
54
KODKodiak Sciences Inc.
Healthcare · Biotechnology
$2.13B+3.2%
P/E —·P/S —·Mgn —·ROE -146.1%·FCF —
—
55
IMNMImmunome Inc.
Healthcare · Pharmaceuticals
$2.08B+0.7%
P/E —·P/S 518.4·Mgn -5593.8%·ROE -33.5%·FCF -9.6%
—
56
HRMYHarmony Biosciences Holdings, Inc.
Healthcare · Pharmaceuticals
$1.99B+3.0%
P/E 13.7·P/S 2.2·Mgn 16.2%·ROE 18.2%·FCF 17.4%
F 5
Red 8-K
57
ADMAADMA BIOLOGICS, INC.
Healthcare · Biotechnology
$1.90B0.0%
P/E 11.5·P/S 3.7·Mgn 32.4%·ROE 30.8%·FCF 1.5%
F 5
58
JBLUJETBLUE AIRWAYS CORP🔥
Industrials · Transportation
$1.86B+1.8%
P/E —·P/S 0.2·Mgn -7.8%·ROE -28.4%·FCF -62.9%
—
13D
59
ANIPANI PHARMACEUTICALS INC
Healthcare · Pharmaceuticals
$1.86B-1.6%
P/E 20.2·P/S 2.0·Mgn 10.0%·ROE 14.5%·FCF 9.2%
—
Red 8-K
60
VRDNViridian Therapeutics, Inc.DE
Healthcare · Pharmaceuticals
$1.81B-2.2%
P/E —·P/S 25.5·Mgn -483.6%·ROE -47.4%·FCF -15.3%
—
13D
61
NRIXNurix Therapeutics, Inc.🔥
Healthcare · Pharmaceuticals
$1.75B+1.7%
P/E —·P/S 24.4·Mgn -411.4%·ROE —·FCF —
—
62
AGIOAGIOS PHARMACEUTICALS, INC.
Healthcare · Pharmaceuticals
$1.75B-2.4%
P/E —·P/S 26.5·Mgn -639.8%·ROE -34.6%·FCF -21.5%
F 2
Red 8-K
63
QUREuniQure N.V.🔥
Healthcare · Pharmaceuticals
$1.74B-2.8%
P/E —·P/S 96.1·Mgn -1154.4%·ROE -100.0%·FCF -10.3%
F 4
Red 8-K
64
BHVNBiohaven Ltd.⚡
Healthcare · Pharmaceuticals
$1.70B-0.5%
P/E —·P/S 2.0·Mgn -108.3%·ROE -1418.8%·FCF —
—
65
NTLAIntellia Therapeutics, Inc.⚡
Healthcare · Diagnostics & Tools
$1.69B+1.9%
P/E —·P/S 25.6·Mgn -597.0%·ROE -61.5%·FCF -23.4%
—
66
RXRXRECURSION PHARMACEUTICALS, INC.
Healthcare · Biotechnology
$1.67B-0.5%
P/E —·P/S 22.4·Mgn -863.4%·ROE -57.0%·FCF -22.6%
F 4
Red 8-K
67
AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
Healthcare · Pharmaceuticals
$1.64B-0.8%
P/E —·P/S 12.2·Mgn -41.4%·ROE -148.0%·FCF -1.1%
—
68
TSHATaysha Gene Therapies, Inc.
Healthcare · Biotechnology
$1.64B+1.2%
P/E —·P/S 219.6·Mgn -1738.4%·ROE -44.1%·FCF -5.7%
—
69
AMLXAmylyx Pharmaceuticals, Inc.
Healthcare · Pharmaceuticals
$1.62B-4.0%
P/E —·P/S —·Mgn —·ROE -47.4%·FCF -7.6%
—
70
SRPTSarepta Therapeutics, Inc.
Healthcare · Pharmaceuticals
$1.62B+5.6%
P/E —·P/S 0.7·Mgn -32.5%·ROE -62.5%·FCF -19.0%
—
Red 8-K
71
PGENPRECIGEN, INC.
Healthcare · Pharmaceuticals
$1.59B-3.7%
P/E —·P/S 50.2·Mgn -647.0%·ROE -1198.6%·FCF -5.7%
—
13DRed 8-K
72
PVLAPALVELLA THERAPEUTICS, INC.
Healthcare · Pharmaceuticals
$1.56B-1.3%
P/E —·P/S 602.6·Mgn -1610.6%·ROE -149.1%·FCF —
—
Red 8-K
73
FTREFortrea Holdings Inc.
Healthcare · Healthcare Services
$1.56B-0.7%
P/E —·P/S 0.6·Mgn -16.5%·ROE -175.0%·FCF 5.7%
—
Red 8-K
74
SLSSELLAS Life Sciences Group, Inc.
Healthcare · Pharmaceuticals
$1.54B-4.5%
P/E —·P/S —·Mgn —·ROE -37.9%·FCF —
—
Red 8-K
75
PRGOPERRIGO Co plc🔥
Healthcare · Pharmaceuticals
$1.52B+3.4%
P/E —·P/S 0.4·Mgn -43.5%·ROE -48.6%·FCF 9.5%
F 4
Red 8-K
76
CAPRCAPRICOR THERAPEUTICS, INC.
Healthcare · Pharmaceuticals
$1.49B+1.2%
P/E —·P/S 67.1·Mgn -181.7%·ROE -34.4%·FCF -4.9%
—
77
IMCRImmunocore Holdings plc
Healthcare · Biotechnology
$1.47B+4.4%
P/E —·P/S 3.6·Mgn -6.7%·ROE -9.3%·FCF -1.0%
F 3
78
URGNUroGen Pharma Ltd.
Healthcare · Pharmaceuticals
$1.45B+2.0%
P/E —·P/S 10.3·Mgn -94.8%·ROE —·FCF -11.2%
F 1
Red 8-K
79
HROWHARROW, INC.
Healthcare · Pharmaceuticals
$1.40B+3.2%
P/E —·P/S 5.2·Mgn -1.9%·ROE -9.8%·FCF 3.1%
F 5
80
IARTINTEGRA LIFESCIENCES HOLDINGS CORP
Healthcare · Medical Devices
$1.38B-4.2%
P/E —·P/S 0.8·Mgn -30.1%·ROE -49.5%·FCF -2.2%
F 5
Red 8-K
81
INBXInhibrx Biosciences, Inc.
Healthcare · Biotechnology
$1.35B-0.8%
P/E —·P/S 1040.5·Mgn -10014.2%·ROE -1752.2%·FCF -9.6%
—
82
AVLNAvalyn Pharma Inc.
Healthcare · Pharmaceuticals
$1.33B+6.2%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
13D
83
XERSXeris Biopharma Holdings, Inc.
Healthcare · Pharmaceuticals
$1.17B+2.3%
P/E 97.6·P/S 3.7·Mgn 3.8%·ROE —·FCF —
—
Dilut.Red 8-K
84
WVEWave Life Sciences Ltd.
Healthcare · Pharmaceuticals
$1.13B+2.3%
P/E —·P/S 15.7·Mgn -255.7%·ROE -39.4%·FCF -16.7%
—
13D
85
MGRTMega Fortune Co Ltd
Technology · Software & IT
$1.02B-3.2%
P/E 1896.6·P/S 313.4·Mgn 16.5%·ROE 11.5%·FCF —
F 3
13D
86
XNCRXencor Inc
Healthcare · Pharmaceuticals
$914M+3.2%
P/E —·P/S 9.4·Mgn -177.1%·ROE -14.5%·FCF -15.1%
—
Red 8-K
87
PHARPharming Group N.V.
Healthcare · Pharmaceuticals
$904M+3.7%
P/E —·P/S 3.7·Mgn -4.3%·ROE 0.9%·FCF 6.0%
—
88
MGTXMeiraGTx Holdings plc
Healthcare · Biotechnology
$888M+7.7%
P/E —·P/S 11.1·Mgn -151.1%·ROE —·FCF -5.7%
—
13D
89
AMPHAmphastar Pharmaceuticals, Inc.
Healthcare · Pharmaceuticals
$886M-2.6%
P/E 11.2·P/S 1.2·Mgn 11.0%·ROE 12.4%·FCF 13.7%
F 6
90
ETONEton Pharmaceuticals, Inc.
Healthcare · Pharmaceuticals
$865M-1.4%
P/E —·P/S 10.8·Mgn -5.8%·ROE -17.6%·FCF 1.2%
F 4
Red 8-K
91
LXRXLEXICON PHARMACEUTICALS, INC.
Healthcare · Pharmaceuticals
$853M-9.1%
P/E —·P/S 12.2·Mgn -37.5%·ROE -46.8%·FCF -8.0%
F 4
13DDilut.
92
CERTCertara, Inc.
Technology · Software
$809M+3.0%
P/E —·P/S 1.9·Mgn -3.6%·ROE -0.2%·FCF 11.7%
—
Red 8-K
93
ZVRAZEVRA THERAPEUTICS, INC.
Healthcare · Pharmaceuticals
$748M+2.4%
P/E 9.0·P/S 7.0·Mgn 78.2%·ROE 53.8%·FCF -0.3%
—
94
REPLReplimune Group, Inc.
Healthcare · Biotechnology
$733M-1.2%
P/E —·P/S —·Mgn —·ROE -59.5%·FCF —
—
95
RLMDRELMADA THERAPEUTICS, INC.
Healthcare · Pharmaceuticals
$698M-0.9%
P/E —·P/S —·Mgn —·ROE -66.3%·FCF —
—
Dilut.
96
CLYMClimb Bio, Inc.
Healthcare · Pharmaceuticals
$655M-2.4%
P/E —·P/S —·Mgn —·ROE -37.3%·FCF —
—
13DDilut.Red 8-K
97
IMMXImmix Biopharma, Inc.
Healthcare · Pharmaceuticals
$602M-1.7%
P/E —·P/S —·Mgn —·ROE -31.4%·FCF —
—
98
IRWDIRONWOOD PHARMACEUTICALS INC
Healthcare · Pharmaceuticals
$601M-2.1%
P/E 5.9·P/S 1.7·Mgn 28.3%·ROE —·FCF 21.1%
—
13DRed 8-K
99
DRUGBRIGHT MINDS BIOSCIENCES INC.
Healthcare · Pharmaceuticals
$598M+1.5%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
100
GYREGYRE THERAPEUTICS, INC.
Healthcare · Pharmaceuticals
$575M+2.2%
P/E —·P/S 4.9·Mgn -1.2%·ROE 9.3%·FCF -0.0%
F 4
13DDilut.Red 8-K
101
FLGTFulgent Genetics, Inc.
Healthcare · Healthcare Services
$531M-0.1%
P/E —·P/S 1.7·Mgn -23.4%·ROE -5.4%·FCF -23.4%
F 3
13DRed 8-K
102
AQSTAquestive Therapeutics, Inc.
Healthcare · Pharmaceuticals
$523M0.0%
P/E —·P/S 10.4·Mgn -137.1%·ROE —·FCF -10.1%
F 2
Dilut.
103
CTKBCytek Biosciences, Inc.
Healthcare · Diagnostics & Tools
$511M+2.1%
P/E —·P/S 2.5·Mgn -33.0%·ROE -19.5%·FCF -1.7%
F 3
Red 8-K
104
VALNValneva SE
Healthcare · Biotechnology
$508M+1.2%
P/E —·P/S 2.9·Mgn -66.0%·ROE -108.5%·FCF -12.9%
—
13D
105
ALTAltimmune, Inc.
Healthcare · Pharmaceuticals
$508M+3.4%
P/E —·P/S —·Mgn —·ROE -39.2%·FCF -13.3%
—
106
PRMEPrime Medicine, Inc.
Healthcare · Biotechnology
$501M-0.8%
P/E —·P/S 124.2·Mgn -4917.6%·ROE -166.4%·FCF -33.3%
—
Red 8-K
107
CABACabaletta Bio, Inc.
Healthcare · Biotechnology
$491M0.0%
P/E —·P/S —·Mgn —·ROE -149.8%·FCF —
—
108
ARVNARVINAS, INC.
Healthcare · Pharmaceuticals
$489M+0.2%
P/E —·P/S 6.2·Mgn -467.9%·ROE -18.6%·FCF -56.4%
—
Red 8-K
109
AGMBAgomab Therapeutics NV
Healthcare · Biotechnology
$473M-27.2%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
110
NGNENeurogene Inc.
Healthcare · Pharmaceuticals
$460M-2.6%
P/E —·P/S —·Mgn —·ROE -34.1%·FCF -17.0%
—
Red 8-K
111
CTNMContineum Therapeutics, Inc.
Healthcare · Pharmaceuticals
$444M+9.3%
P/E —·P/S —·Mgn —·ROE -23.0%·FCF —
—
112
PRTAPROTHENA CORP PUBLIC LTD CO
Healthcare · Pharmaceuticals
$432M-1.8%
P/E —·P/S 7.5·Mgn -260.9%·ROE -87.0%·FCF —
—
113
OVIDOvid Therapeutics Inc.
Healthcare · Pharmaceuticals
$429M-1.1%
P/E —·P/S 60.3·Mgn -339.3%·ROE -13.3%·FCF -8.9%
—
Dilut.Red 8-K
114
AUTLAutolus Therapeutics plc
Healthcare · Biotechnology
$415M-3.0%
P/E —·P/S 5.5·Mgn -381.4%·ROE -161.4%·FCF -72.9%
F 2
Red 8-K
115
OCGNOcugen, Inc.🔥
Healthcare · Biotechnology
$410M-8.4%
P/E —·P/S 91.7·Mgn -1605.2%·ROE —·FCF -14.0%
—
Dilut.Red 8-K
116
PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Healthcare · Diagnostics & Tools
$407M-2.9%
P/E —·P/S 2.5·Mgn -80.3%·ROE -10214.5%·FCF -28.0%
F 3
Red 8-K
117
IPSCCentury Therapeutics, Inc.
Healthcare · Biotechnology
$406M+1.7%
P/E —·P/S —·Mgn —·ROE -6.0%·FCF -25.8%
—
Red 8-K
118
INDPIndaptus Therapeutics, Inc.
Healthcare · Pharmaceuticals
$405M-2.0%
P/E —·P/S —·Mgn —·ROE -127.7%·FCF —
—
13DDilut.Red 8-K
119
DCTHDELCATH SYSTEMS, INC.
Healthcare · Medical Devices
$405M-2.8%
P/E 721.2·P/S 4.5·Mgn 0.6%·ROE 2.4%·FCF 5.2%
F 7
Red 8-K
120
LSAKLESAKA TECHNOLOGIES INC
Financials · Banks
$403M+4.0%
P/E —·P/S 0.6·Mgn -13.3%·ROE -54.1%·FCF -6.5%
F 3
13DRed 8-K
121
MNPRMonopar Therapeutics
Healthcare · Pharmaceuticals
$400M-2.1%
P/E —·P/S —·Mgn —·ROE -10.0%·FCF —
—
122
RZLTRezolute, Inc.
Healthcare · Pharmaceuticals
$385M+2.0%
P/E —·P/S —·Mgn —·ROE -45.9%·FCF —
—
123
BNTCBenitec Biopharma Inc.
Healthcare · Pharmaceuticals
$384M+5.3%
P/E —·P/S —·Mgn —·ROE -39.0%·FCF —
—
Red 8-K
124
EDITEditas Medicine, Inc.
Healthcare · Biotechnology
$384M+1.3%
P/E —·P/S 9.9·Mgn -281.6%·ROE -586.6%·FCF -43.2%
—
Red 8-K
125
XFORX4 Pharmaceuticals, Inc
Healthcare · Biotechnology
$377M+10.4%
P/E —·P/S 147.5·Mgn -1464.6%·ROE -42.5%·FCF -22.7%
F 4
Red 8-K
126
LRMRLarimar Therapeutics, Inc.
Healthcare · Pharmaceuticals
$360M-4.7%
P/E —·P/S —·Mgn —·ROE -212.2%·FCF —
—
127
VSTMVerastem, Inc.
Healthcare · Pharmaceuticals
$360M0.0%
P/E —·P/S 7.3·Mgn -391.2%·ROE -366.2%·FCF —
—
128
AVIRAtea Pharmaceuticals, Inc.
Healthcare · Pharmaceuticals
$359M+0.9%
P/E —·P/S —·Mgn —·ROE -57.5%·FCF —
—
129
VNDAVanda Pharmaceuticals Inc.
Healthcare · Pharmaceuticals
$353M-0.3%
P/E —·P/S 1.6·Mgn -110.0%·ROE -67.4%·FCF -31.3%
—
Red 8-K
130
IRDOpus Genetics, Inc.
Healthcare · Pharmaceuticals
$334M+1.2%
P/E —·P/S 23.5·Mgn -349.3%·ROE -323.1%·FCF —
—
13DDilut.Red 8-K
131
UPBUpstream Bio, Inc.
Healthcare · Pharmaceuticals
$332M-0.1%
P/E —·P/S 116.3·Mgn -5026.0%·ROE -42.2%·FCF -40.2%
—
132
ABEOABEONA THERAPEUTICS INC.
Healthcare · Pharmaceuticals
$315M+9.2%
P/E —·P/S —·Mgn —·ROE 44.7%·FCF -26.7%
—
Red 8-K
133
CLLSCellectis S.A.
Healthcare · Biotechnology
$311M+2.0%
P/E —·P/S —·Mgn —·ROE -89.1%·FCF -13.4%
—
134
RNACCartesian Therapeutics, Inc.
Healthcare · Pharmaceuticals
$279M+8.1%
P/E —·P/S 99.9·Mgn -4658.6%·ROE —·FCF -28.4%
—
13DDilut.Red 8-K
135
NAGENiagen Bioscience, Inc.
Healthcare · Pharmaceuticals
$275M-3.3%
P/E 15.8·P/S 2.1·Mgn 13.4%·ROE 22.7%·FCF —
F 6
136
ZNTLZentalis Pharmaceuticals, Inc.
Healthcare · Pharmaceuticals
$267M+5.2%
P/E —·P/S —·Mgn —·ROE -63.4%·FCF -46.9%
—
Red 8-K
137
TRDAEntrada Therapeutics, Inc.
Healthcare · Pharmaceuticals
$251M-4.5%
P/E —·P/S 43.7·Mgn -2895.1%·ROE -47.0%·FCF -51.7%
—
Red 8-K
138
AKBAAkebia Therapeutics, Inc.
Healthcare · Pharmaceuticals
$248M+2.7%
P/E —·P/S 1.1·Mgn -8.8%·ROE -16.4%·FCF 27.3%
F 6
139
PROFProfound Medical Corp.
Healthcare · Medical Devices
$241M+0.9%
P/E —·P/S 12.8·Mgn -206.8%·ROE -64.1%·FCF -15.9%
F 3
140
SLGLSol-Gel Technologies Ltd.
Healthcare · Pharmaceuticals
$240M-0.4%
P/E —·P/S 63.2·Mgn -161.2%·ROE -26.9%·FCF 0.1%
—
13D
141
IFRXInflaRx N.V.
Healthcare · Pharmaceuticals
$236M-1.8%
P/E —·P/S —·Mgn —·ROE -109.8%·FCF -17.1%
—
142
ACIUAC Immune SA
Healthcare · Pharmaceuticals
$235M-10.5%
P/E —·P/S 12.9·Mgn -366.4%·ROE -157.0%·FCF -36.9%
—
143
AVXLANAVEX LIFE SCIENCES CORP.
Healthcare · Biotechnology
$232M-0.4%
P/E —·P/S 49.5·Mgn -991.4%·ROE -48.9%·FCF —
—
Red 8-K
144
FULCFulcrum Therapeutics, Inc.⚡
Healthcare · Pharmaceuticals
$230M-1.9%
P/E —·P/S 2.9·Mgn -12.2%·ROE -21.5%·FCF -26.3%
—
Red 8-K
145
TARAProtara Therapeutics, Inc.
Healthcare · Biotechnology
$219M-8.2%
P/E —·P/S —·Mgn —·ROE -29.2%·FCF —
—
Red 8-K
146
CDXSCODEXIS, INC.
Materials · Chemicals
$218M-3.0%
P/E —·P/S 2.8·Mgn -41.0%·ROE -87.0%·FCF -10.9%
F 4
Red 8-K
147
CAMPCamp4 Therapeutics Corp
Healthcare · Pharmaceuticals
$218M-1.6%
P/E —·P/S 55.3·Mgn -2193.7%·ROE -168.5%·FCF -13.7%
—
13DRed 8-K
148
UTMDUTAH MEDICAL PRODUCTS INC
Healthcare · Medical Devices
$216M-5.6%
P/E 19.9·P/S 5.8·Mgn 28.9%·ROE 9.5%·FCF 6.6%
F 6
149
CHRSCoherus Oncology, Inc.
Healthcare · Biotechnology
$216M-3.5%
P/E —·P/S 0.1·Mgn -0.5%·ROE 275.4%·FCF —
F 6
Red 8-K
150
LENZLENZ Therapeutics, Inc.
Healthcare · Biotechnology
$212M-1.4%
P/E —·P/S 11.1·Mgn -430.3%·ROE -28.9%·FCF -33.0%
—
151
VYGRVoyager Therapeutics, Inc.
Healthcare · Biotechnology
$211M-2.2%
P/E —·P/S 5.8·Mgn -319.6%·ROE -61.1%·FCF -63.9%
—
Red 8-K
152
WHWKWhitehawk Therapeutics, Inc.
Healthcare · Pharmaceuticals
$206M+3.9%
P/E —·P/S 28.8·Mgn -288.3%·ROE -15.1%·FCF -47.6%
F 4
13DDilut.
153
KROSKeros Therapeutics, Inc.
Healthcare · Pharmaceuticals
$201M-2.1%
P/E 2.3·P/S 0.8·Mgn 35.7%·ROE 28.7%·FCF 52.7%
—
Red 8-K
154
UNCYUnicycive Therapeutics, Inc.
Healthcare · Pharmaceuticals
$199M-39.1%
P/E —·P/S —·Mgn —·ROE -87.9%·FCF —
—
Red 8-K
155
ARCTArcturus Therapeutics Holdings Inc.
Healthcare · Pharmaceuticals
$198M-1.5%
P/E —·P/S 3.6·Mgn -143.8%·ROE -30.7%·FCF -37.6%
—
Red 8-K
156
CGENCOMPUGEN LTD
Healthcare · Biotechnology
$193M-0.9%
P/E —·P/S —·Mgn —·ROE 34.4%·FCF 16.2%
F 7
157
IMUXIMMUNIC, INC.
Healthcare · Pharmaceuticals
$189M-0.3%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
Red 8-K
158
TNXPTonix Pharmaceuticals Holding Corp.
Healthcare · Pharmaceuticals
$181M+0.1%
P/E —·P/S 10.3·Mgn -839.5%·ROE -50.6%·FCF -57.0%
F 5
Red 8-K
159
ABOSAcumen Pharmaceuticals, Inc.
Healthcare · Biotechnology
$171M-3.6%
P/E —·P/S —·Mgn —·ROE -172.3%·FCF —
—
13DDilut.
160
ANTXAN2 Therapeutics, Inc.
Healthcare · Pharmaceuticals
$171M-3.8%
P/E —·P/S —·Mgn —·ROE -62.7%·FCF —
—
Dilut.
161
PLXProtalix BioTherapeutics, Inc.
Healthcare · Biotechnology
$168M-0.8%
P/E 11.0·P/S 2.2·Mgn 20.1%·ROE -13.7%·FCF -8.1%
F 1
162
KRROKorro Bio, Inc.
Healthcare · Pharmaceuticals
$167M-0.1%
P/E —·P/S 43.6·Mgn -2954.1%·ROE -228.0%·FCF -47.2%
—
13DDilut.
163
SPROSpero Therapeutics, Inc.
Healthcare · Pharmaceuticals
$165M-2.2%
P/E 10.8·P/S 2.7·Mgn 24.9%·ROE 14.5%·FCF —
—
Red 8-K
164
KZIAKAZIA THERAPEUTICS LTD
Healthcare · Pharmaceuticals
$163M-2.6%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
165
MISTMilestone Pharmaceuticals Inc.
Healthcare · Pharmaceuticals
$158M+0.8%
P/E —·P/S —·Mgn —·ROE -151.0%·FCF —
—
Red 8-K
166
DTILPRECISION BIOSCIENCES INC
Healthcare · Biotechnology
$157M-0.8%
P/E —·P/S 3.5·Mgn -96.7%·ROE -49.6%·FCF -41.9%
—
Red 8-K
167
CRBPCorbus Pharmaceuticals Holdings, Inc.🔥
Healthcare · Pharmaceuticals
$152M+4.5%
P/E —·P/S 28.9·Mgn -1609.8%·ROE -53.2%·FCF —
—
Red 8-K
168
PRQRProQR Therapeutics N.V.
Healthcare · Pharmaceuticals
$152M+1.6%
P/E —·P/S 98.3·Mgn -4490.3%·ROE -85.4%·FCF -40.4%
—
13D
169
HURATuHURA Biosciences, Inc./NV
Healthcare · Pharmaceuticals
$148M+2.2%
P/E —·P/S —·Mgn —·ROE -143.6%·FCF -18.8%
—
Dilut.Red 8-K
170
TLSATiziana Life Sciences Ltd
Healthcare · Pharmaceuticals
$140M+4.1%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
171
AGENAGENUS INC
Healthcare · Biotechnology
$137M-2.9%
P/E 2.2·P/S 1.1·Mgn 50.5%·ROE —·FCF -56.2%
F 4
Red 8-K
172
NTHINEONC TECHNOLOGIES HOLDINGS, INC.
Healthcare · Pharmaceuticals
$124M+2.3%
P/E —·P/S —·Mgn —·ROE —·FCF -16.9%
—
Dilut.
173
CRDLCardiol Therapeutics Inc.
Healthcare · Biotechnology
$119M+2.9%
P/E —·P/S —·Mgn —·ROE -41.5%·FCF -13.9%
—
174
PLYXPolaryx Therapeutics, Inc.
Healthcare · Pharmaceuticals
$118M+5.1%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
Dilut.
175
RFLRafael Holdings, Inc.
Healthcare · Pharmaceuticals
$116M+3.8%
P/E —·P/S —·Mgn —·ROE -32.3%·FCF -16.3%
—
176
XGNEXAGEN INC.
Healthcare · Healthcare Services
$113M-2.1%
P/E —·P/S 1.6·Mgn -29.5%·ROE -114.3%·FCF -12.6%
F 3
Red 8-K
177
CRDFCardiff Oncology, Inc.
Healthcare · Biotechnology
$105M+2.4%
P/E —·P/S —·Mgn —·ROE -101.0%·FCF -36.1%
—
Red 8-K
178
KLRSKalaris Therapeutics, Inc.
Healthcare · Biotechnology
$103M-3.4%
P/E —·P/S —·Mgn —·ROE —·FCF -19.9%
—
13DRed 8-K
179
PUSAAureus Greenway Holdings Inc
Consumer Discretionary
$102M-1.5%
P/E —·P/S 30.9·Mgn -5.6%·ROE -11.2%·FCF -3.0%
—
13DDilut.
180
PMNProMIS Neurosciences Inc.
Healthcare · Pharmaceuticals
$93M+22.4%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
Red 8-K
181
RLYBRallybio Corp
Healthcare · Pharmaceuticals
$92M-0.4%
P/E —·P/S —·Mgn —·ROE -15.5%·FCF —
—
13DDilut.Red 8-K
182
IBIOiBio, Inc.
Healthcare · Pharmaceuticals
$84M+1.2%
P/E —·P/S —·Mgn —·ROE -123.5%·FCF -18.2%
—
Red 8-K
183
CPIXCUMBERLAND PHARMACEUTICALS INC
Healthcare · Pharmaceuticals
$84M-5.3%
P/E —·P/S 2.0·Mgn -17.6%·ROE -11.4%·FCF 5.8%
F 6
184
MAIAMAIA Biotechnology, Inc.
Healthcare · Pharmaceuticals
$79M-2.7%
P/E —·P/S —·Mgn —·ROE -942.7%·FCF —
—
185
OSTXOS Therapies Inc
Healthcare · Pharmaceuticals
$76M-15.2%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
Dilut.
186
GANXGain Therapeutics, Inc.
Healthcare · Pharmaceuticals
$72M+2.5%
P/E —·P/S —·Mgn —·ROE -108.6%·FCF —
—
187
PLRXPLIANT THERAPEUTICS, INC.
Healthcare · Pharmaceuticals
$70M-0.9%
P/E —·P/S —·Mgn —·ROE -82.4%·FCF -184.0%
—
Red 8-K
188
EXOZEXOZYMES INC.
Healthcare · Biotechnology
$65M+0.1%
P/E —·P/S —·Mgn —·ROE -269.6%·FCF —
—
189
ENTXEntera Bio Ltd.
Healthcare · Biotechnology
$61M+7.3%
P/E —·P/S —·Mgn —·ROE -87.3%·FCF -12.3%
F 2
Dilut.
190
INKTMiNK Therapeutics, Inc.
Healthcare · Biotechnology
$60M-1.9%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
191
LUNGPulmonx Corp
Healthcare · Medical Devices
$58M-2.3%
P/E —·P/S 0.7·Mgn -60.1%·ROE -99.8%·FCF -56.7%
F 3
Dilut.
192
TILInstil Bio, Inc.
Healthcare · Biotechnology
$54M+2.1%
P/E —·P/S —·Mgn —·ROE -62.7%·FCF —
—
Red 8-K
193
DWTXDogwood Therapeutics, Inc.
Healthcare · Pharmaceuticals
$52M-9.6%
P/E —·P/S —·Mgn —·ROE -45.7%·FCF —
—
194
DRIODarioHealth Corp.
Healthcare · Medical Devices
$52M-2.9%
P/E —·P/S 2.4·Mgn -192.2%·ROE -61.4%·FCF -50.5%
F 4
Red 8-K
Filings · filterAll10-K10-Q8-KS-1DEF 14ASC 13D

Filings

40 shown
OLOXOLENOX INDUSTRIES INC.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 30, 2026·22h ago
AIHSSenmiao Technology Ltd
10-K

Annual report — full-year financials, business overview, and risk factors.

Companies above the $50M market cap · $1 pricefloor; SPAC/shells hidden by default. Fundamentals & prices via Polygon · signals from SEC EDGAR — verify on SEC.gov. Filings current to Jun 30 · prices to Jun 30.
Jun 30, 2026
·
23h ago
TEL INSTRUMENT ELECTRONICS CORP
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 30, 2026·1d ago
SCORES HOLDING CO INC
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 30, 2026·1d ago
BENFWBeneficient
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 30, 2026·1d ago
AGSSAMERIGUARD SECURITY SERVICES, INC.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
PETVWPetVivo Holdings, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
MODDModular Medical, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
21Shares Polkadot ETF
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
AVAVAeroVironment Inc
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
EZETFranklin Ethereum Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
EZBCFranklin Templeton Digital Holdings Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
FGDLFranklin Templeton Holdings Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
XRPZFranklin XRP Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
SOEZFranklin Solana Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
QDMIQDM International Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
PODCPodcastOne, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
LVOLiveOne, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
RDZNWRoadzen Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
ELTPELITE PHARMACEUTICALS INC /NV/
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
ATXGADDENTAX GROUP CORP.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
SUNDSundance Strategies, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
MEDICAL EXERCISE INC.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
GRVEGROOVE BOTANICALS INC.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
MMEDMiniMed Group, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
AIRTPAIR T INC
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
REPLReplimune Group, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
PMNTPerfect Moment Ltd.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
MXCMEXCO ENERGY CORP
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 29, 2026·2d ago
KEQUKEWAUNEE SCIENTIFIC CORP /DE/
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·4d ago
KFYKORN FERRY
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·4d ago
XAIRBeyond Air, Inc.
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·4d ago
MSNEMERSON RADIO CORP
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·4d ago
Nissan Auto Receivables 2025-B Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago
Nissan Auto Receivables 2025-A Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago
Nissan Auto Receivables 2024-B Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago
Nissan Auto Receivables 2024-A Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago
Nissan Auto Receivables 2023-B Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago
Nissan Auto Receivables 2023-A Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago
Nissan Auto Receivables 2022-B Owner Trust
10-K

Annual report — full-year financials, business overview, and risk factors.

Jun 26, 2026·5d ago